NCT03188601View on ClinicalTrials.gov

α1-antitrypsin (AAT) Levels and Functions in Allogeneic Bone Marrow Transplantation and Throughout Progression Into GVHD

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 27, 2018

Primary Completion Date

February 1, 2022

Study Completion Date

August 1, 2022

Conditions

GVHDBone Marrow Transplant FailureAlpha 1-Antitrypsin

Trial Locations (4)

91120

Hadassah, Jerusalem

3525408

Rambam MC, Haifa

6423906

Tel Aviv Sourasky Medical Center - Ichilov Hospital, Tel Aviv

8410101

Soroka Medical Center, Beersheba

All Listed Sponsors

collaborator

Soroka University Medical Center

OTHER

collaborator

Tel-Aviv Sourasky Medical Center

OTHER_GOV

collaborator

Hadassah Medical Organization

OTHER

lead

Rambam Health Care Campus

OTHER

NCT03188601 - α1-antitrypsin (AAT) Levels and Functions in Allogeneic Bone Marrow Transplantation and Throughout Progression Into GVHD | Biotech Hunter | Biotech Hunter